This opportunity seeks to develop a transformative, end-to-end resuscitation system for far-forward trauma care, aiming to replace stored whole blood without cold chain or donor logistics. The system includes a blood analog with sequentially administered components, ruggedized delivery, diagnostics, and clinical guidelines. The program will advance components to Technology Readiness Level 7 and devices to TRL 8, with a focus on regulatory and commercialization strategies. Proposals are requested for Phase 1 of Task Area 1 and/or Task Area 2 only. No budget amounts, performance location, or submission timelines are specified.

This program seeks to develop a fieldable, scalable blood analog system for far-forward trauma care, removing dependence on cold chain and donor logistics. It aims to integrate sequentially administered blood analog components with ruggedized delivery, diagnostics, and clinical guidelines. The effort will advance components to Technology Readiness Level 7 and devices to TRL 8 through regulatory and commercialization strategies. Proposals are requested for Phase 1 of Task Area 1 and/or Task Area 2 only. No specific budget, performance location, or non-bid timelines are mentioned in the description.